Pure Global

Wecare Study in Gastric Cancer Survivors - Trial NCT06395935

Access comprehensive clinical trial information for NCT06395935 through Pure Global AI's free database. This phase not specified trial is sponsored by Gyeongsang National University Hospital and is currently Recruiting. The study focuses on Gastric Cancer. Target enrollment is 88 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06395935
Recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT06395935
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Wecare Study in Gastric Cancer Survivors
A Multi-center, Prospective, Randomized Study to Evaluate the Usefulness of Applying the Chronic Side Effect Management Platform (Wecare) in Gastric Cancer Survivors

Study Focus

Gastric Cancer

Wecare (website)

Interventional

other

Sponsor & Location

Gyeongsang National University Hospital

Changwon, South Korea

Timeline & Enrollment

N/A

Apr 01, 2024

Mar 30, 2026

88 participants

Primary Outcome

the quality of life in gastric cancer survivor (KOQUSS-40)

Summary

The KOrean QUality of life in Stomach cancer patients Study group (KOQUSS) made a method
 (KOQUSS-40) for assessing appropriately the quality of life of gastric cancer patients who
 have undergone gastrectomy, and developed a digital platform (Wecare) based on KOQUSS-40. In
 this study, we propose a randomized controlled trial to compare quality of life after
 gastrectomy in patients with and without smartphone app support.

ICD-10 Classifications

Gastric ulcer
Malignant neoplasm of stomach
Malignant neoplasm: Body of stomach
Carcinoma in situ: Stomach
Malignant neoplasm: Stomach, unspecified

Data Source

ClinicalTrials.gov

NCT06395935

Non-Device Trial